TJ Deng – GM China & Ian Wisenberg – CFO, BioDuro, China

TJ Deng, GM China and BioDuro Discovery; and Ian Wisenberg, CFO of BioDuro, share the strategic rationale behind Advent International’s 2019 investment into the company; the focus of BioDuro 4.0 on growth, particularly in the US and Chinese markets; the differentiated and value-added services BioDuro can offer clients; and their core focus on offering integrated drug discovery and development solutions to the global industry.  
BioDuro 4.0 is really about explosive growth. Tangibly, in three years, we are looking to double our current size in both China and the US
Become a PharmaBoardroom Member for free to access this content
Join the 35,000+ pharmaceutical professionals who already subscribe to PharmaBoardroom
Already a member? Sign In

Related Interviews

Latest Report